Metabolic syndrome and lower urinary tract symptoms in patients with benign prostatic enlargement: A possible link to storage symptoms

Urology

Volumn 84, Issue 5, 2014, Pages 1181-1187

  De Nunzio, Cosimo ^a   Cindolo, Luca ^b   Gacci, Mauro ^c   Pellegrini, Fabrizio ^b   Carini, Marco ^c   Lombardo, Riccardo ^a   Franco, Giorgio ^d   Tubaro, Andrea ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Ospedale San Pio da Pietrelcina   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d POLICLINICO UMBERTO I   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; BODY MASS; CLINICAL EVALUATION; COMORBIDITY; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; LOGISTIC REGRESSION ANALYSIS; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSTATE HYPERTROPHY; PROSTATE VOLUME; STORAGE DISEASE; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; BLOOD; COMPLICATION; ECHOGRAPHY; PROSTATE; RISK FACTOR; STATISTICAL MODEL;

AGED; BLOOD PRESSURE; BODY MASS INDEX; HUMANS; LIPOPROTEINS, HDL; LOGISTIC MODELS; LOWER URINARY TRACT SYMPTOMS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; RISK FACTORS; TESTOSTERONE; WAIST CIRCUMFERENCE;

EID: 84908340355     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2014.07.018     Document Type: Article

References (25)

1. G. Kramer, and M. Marberger Could inflammation be a key component in the progression of benign prostatic hyperplasia? Curr Opin Urol 16 2006 25 29
2. C. De Nunzio, S. Albisinni, and M. Gacci The role of inflammation in the progression of benign prostatic hyperplasia Curr Bladder Dysfunct Rep 8 2013 142 149
3. E.A. Platz, C.E. Joshu, and A.M. Mondul Incidence and progression of lower urinary tract symptoms in a large prospective cohort of United States men J Urol 188 2012 496 501
4. C. De Nunzio, G. Kramer, and M. Marberger The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation Eur Urol 60 2011 106 117
5. A. Briganti, U. Capitanio, and N. Suardi Benign prostatic hyperplasia and its aetiologies Eur Urol Suppl 8 2009 865 871
6. C. De Nunzio, S.J. Freedland, and R. Miano Metabolic syndrome is associated with high grade Gleason score when prostate cancer is diagnosed on biopsy Prostate 71 2011 1492 1498
7. C. De Nunzio, W. Aronson, and S.J. Freedland The correlation between metabolic syndrome and prostatic diseases Eur Urol 61 2012 560 570
8. H. Kwon, H.C. Kang, and J.H. Lee Relationship between predictors of the risk of clinical progression of benign prostatic hyperplasia and metabolic syndrome in men with moderate to severe lower urinary tract symptoms Urology 81 2013 1325 1329
9. J. Hammarsten, B. Hogstedt, and N. Holthuis Components of the metabolic syndrome - risk factors for the development of benign prostatic hyperplasia Prostate Cancer Prostatic Dis 1 1998 157 162
10. S. Rohrmann, E. Smith, and E. Giovannucci Association between markers of the metabolic syndrome and lower urinary tract symptoms in the Third National Health and Nutrition Examination Survey (NHANES III) Int J Obes (Lond) 29 2005 310 316
11. J. Hammarsten, and B. Hogstedt Hyperinsulinemia as a risk factor for developing benign prostatic hyperplasia Eur Urol 39 2001 151 158
12. C. Temml, R. Obermayr, and M. Marszalek Are lower urinary tract symptoms influenced by metabolic syndrome? Urology 73 2009 544 548
13. G.S. Hong, B.S. Shim, and W.S. Chung Correlation between metabolic syndrome and lower urinary tract symptoms of males and females in the aspect of gender specific medicine: a single institutional study Korean J Urol 51 2010 631 635
14. A. Gupta, S. Gupta, and M. Pavuk Anthropometric and metabolic factors and risk of benign prostatic hyperplasia: a prospective cohort study of Air Force veterans Urology 68 2006 1198 1205
15. H.K. Park, H.W. Lee, and K.S. Lee Relationship between lower urinary tract symptoms and metabolic syndrome in a community-based elderly population Urology 72 2008 556 560
16. Y. Gao, M. Wang, and H. Zhang Are metabolic syndrome and its components associated with lower urinary tract symptoms? Results from a Chinese male population survey Urology 79 2012 194 201
17. K. Ohgaki, N. Hikima, and K. Horiuchi Association between metabolic syndrome and male lower urinary tract symptoms in Japanese subjects using three sets of criteria for metabolic syndrome and International Prostate Symptom Score Urology 77 2011 1432 1438
18. V. Kupelian, K.T. McVary, and S.A. Kaplan Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston Area Community Health Survey J Urol 182 2009 616 624
19. Y.C. Lee, C.C. Liu, and Y.S. Juan The impact of metabolic syndrome on the responsiveness to α1-blocker in men with BPH/LUTS Int J Clin Pract 67 2013 356 362
20. M. Gacci, L. Vignozzi, and A. Sebastianelli Metabolic syndrome and lower urinary tract symptoms: the role of inflammation Prostate Cancer Prostatic Dis 16 2013 101 106
21. S.M. Grundy, J.I. Cleeman, and S.R. Daniels Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Circulation 112 2005 2735 2752
22. N. Makhsida, J. Shah, and G. Yang Hypogonadism and metabolic syndrome: implications for testosterone therapy J Urol 174 2006 827 834
23. J.K. Parsons Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems J Urol 178 2007 395 401
24. J.K. Parsons, H.B. Carter, and A.W. Partin Metabolic factors associated with benign prostatic hyperplasia J Clin Endocrinol Metab 91 2006 2562 2568
25. M.G. Kirby, A. Wagg, and L. Cardozo Overactive bladder: is there a link to the metabolic syndrome in men? Neurourol Urodyn 29 2010 1360 1364